Giacomo Giulio Baldi

2.7k total citations
71 papers, 1.6k citations indexed

About

Giacomo Giulio Baldi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Giacomo Giulio Baldi has authored 71 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 38 papers in Oncology and 24 papers in Rheumatology. Recurrent topics in Giacomo Giulio Baldi's work include Sarcoma Diagnosis and Treatment (36 papers), Vascular Tumors and Angiosarcomas (18 papers) and Colorectal Cancer Treatments and Studies (13 papers). Giacomo Giulio Baldi is often cited by papers focused on Sarcoma Diagnosis and Treatment (36 papers), Vascular Tumors and Angiosarcomas (18 papers) and Colorectal Cancer Treatments and Studies (13 papers). Giacomo Giulio Baldi collaborates with scholars based in Italy, United States and United Kingdom. Giacomo Giulio Baldi's co-authors include Silvia Stacchiotti, Alessandro Gronchi, Alfredo Falcone, Fotios Loupakis, Gianluca Masi, Paolo G. Casali, Angelo Paolo Dei Tos, Bruno Vincenzi, Lorenzo Fornaro and Domenico Andrea Campanacci and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Giacomo Giulio Baldi

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giacomo Giulio Baldi Italy	20	843	838	526	287	285	71	1.6k
Horia Sı̂rbu Germany	22	744 0.9×	357 0.4×	175 0.3×	103 0.4×	27 0.1×	89	1.6k
Kuniyasu Shimokawa Japan	18	435 0.5×	279 0.3×	202 0.4×	102 0.4×	70 0.2×	113	1.2k
Shunzo Maetani Japan	17	521 0.6×	379 0.5×	122 0.2×	19 0.1×	174 0.6×	55	1.4k
Lea F. Surrey United States	21	344 0.4×	150 0.2×	158 0.3×	16 0.1×	131 0.5×	76	1.2k
Philippe Dartevelle France	17	817 1.0×	83 0.1×	134 0.3×	95 0.3×	36 0.1×	42	1.1k
P. Bignami Italy	19	418 0.5×	978 1.2×	136 0.3×	79 0.3×	902 3.2×	39	1.6k
Ettore Pelosi Italy	25	668 0.8×	291 0.3×	62 0.1×	39 0.1×	32 0.1×	53	1.7k
Patrizia Dall’Igna Italy	23	578 0.7×	504 0.6×	308 0.6×	26 0.1×	187 0.7×	96	1.7k
Eugenio Salizzoni Italy	18	500 0.6×	327 0.4×	141 0.3×	32 0.1×	46 0.2×	27	1.4k
Jessica L. Davis United States	18	1.2k 1.4×	499 0.6×	450 0.9×	39 0.1×	8 0.0×	64	1.7k

Countries citing papers authored by Giacomo Giulio Baldi

Since Specialization

Citations

This map shows the geographic impact of Giacomo Giulio Baldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giacomo Giulio Baldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giacomo Giulio Baldi more than expected).

Fields of papers citing papers by Giacomo Giulio Baldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giacomo Giulio Baldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giacomo Giulio Baldi. The network helps show where Giacomo Giulio Baldi may publish in the future.

Co-authorship network of co-authors of Giacomo Giulio Baldi

This figure shows the co-authorship network connecting the top 25 collaborators of Giacomo Giulio Baldi. A scholar is included among the top collaborators of Giacomo Giulio Baldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giacomo Giulio Baldi. Giacomo Giulio Baldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stacchiotti, Silvia, et al.. (2025). The impact of the new European CTR on academic clinical research: A survey by the Italian Sarcoma Group Federated Trial Centre. Tumori Journal. 111(3). 246–252.

Baldi, Giacomo Giulio, et al.. (2024). The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments. Frontiers in Oncology. 14. 1367237–1367237. 1 indexed citations

Stacchiotti, Silvia, Giacomo Giulio Baldi, Anna Maria Frezza, et al.. (2023). Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study. European Journal of Cancer. 195. 113391–113391. 8 indexed citations

Miceli, Rosalba, Giacomo Giulio Baldi, Antonella Brunello, et al.. (2023). Outcome of patients (PTS) with advanced epithelioid hemangioendothelioma (EHE) after failure on sirolimus (S).. Journal of Clinical Oncology. 41(16_suppl). 11574–11574.

D’Ambrosio, Lorenzo, Alessandra Merlini, Antonella Brunello, et al.. (2023). LBA91 TOMAS2: A randomized phase II study from the Italian Sarcoma Group (ISG) of trabectedin plus olaparib (T+O) or trabectedin (T) in advanced, metastatic, or unresectable soft tissue sarcomas (STS) after failure of standard treatments. Annals of Oncology. 34. S1332–S1332. 8 indexed citations

Zagami, Paola, Alessandro Comandone, Marco Fiore, et al.. (2023). The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers. Cancer Medicine. 12(16). 17047–17055. 2 indexed citations

Baldi, Giacomo Giulio, Salvatore Lo Vullo, Giovanni Grignani, et al.. (2022). Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case‐series analysis from the Italian Rare Cancers Network. Cancer. 128(7). 1439–1448. 7 indexed citations

Ciniselli, Chiara Maura, Chiara Colombo, Silvia Stacchiotti, et al.. (2021). Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid‐type fibromatosis. Cancer Medicine. 10(13). 4356–4365. 8 indexed citations

Lavacchi, Daniele, Luca Voltolini, Camilla Comin, et al.. (2021). Primary pleural epithelioid hemangioendothelioma: case report and review of the literature. Anti-Cancer Drugs. 32(10). 1131–1137. 3 indexed citations

10.

Grosso, Federica, Lorenzo D’Ambrosio, Massimo Zucchetti, et al.. (2020). Pharmacokinetics, safety, and activity of trabectedin as first‐line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group. Cancer. 126(21). 4726–4734. 20 indexed citations

11.

Trama, Annalisa, Giuseppe Badalamenti, Giacomo Giulio Baldi, et al.. (2019). Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes. Cancer Epidemiology. 59. 258–264. 22 indexed citations

12.

Sanfilippo, Roberta, Chiara Fabbroni, Elena Fumagalli, et al.. (2019). Reversion of resistance to mTOR inhibitors with the addition of exemestane in patients with malignant PEComa. Annals of Oncology. 30. v696–v697. 1 indexed citations

13.

Fiore, Marco, Chiara Colombo, Stefano Radaelli, et al.. (2015). Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis. European Journal of Cancer. 51(18). 2800–2807. 51 indexed citations

14.

Stacchiotti, Silvia, Monica Tortoreto, Giacomo Giulio Baldi, et al.. (2014). Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour. European Journal of Cancer. 50(17). 3021–3028. 51 indexed citations

15.

Vincenzi, Bruno, Anna Maria Frezza, Gaia Schiavon, et al.. (2013). Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment options. PubMed. 3(1). 6–6. 22 indexed citations

16.

Baldi, Giacomo Giulio, Luna Gargani, Antonio Carlos Abramo, et al.. (2012). Lung water assessment by lung ultrasonography in intensive care: a pilot study. Intensive Care Medicine. 39(1). 74–84. 106 indexed citations

17.

Masi, Gianluca, Fotios Loupakis, Luca Emanuele Pollina, et al.. (2009). Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases. Annals of Surgery. 249(3). 420–425. 165 indexed citations

18.

Masi, Gianluca, Fotios Loupakis, Giacomo Giulio Baldi, et al.. (2008). First-line treatment of metastatic colorectal cancer (MCRC) with folfoxiri (irinotecan, oxaliplatin and infusional 5FU/LV) in combination with bevacizumab (BV): A phase II study by the G.O.N.O. Group. CINECA IRIS Institutial research information system (University of Pisa). 2 indexed citations

19.

Masi, Gianluca, Fotios Loupakis, Giacomo Giulio Baldi, et al.. (2007). The combination of capecitabine (C), irinotecan (I) and oxaliplatin (O) (XELOXIRI) as first line treatment of metastatic colorectal cancer (MCRC): Preliminary results of a pilot study by the Gruppo Oncologico Nord-Ovest (G.O.N.O.). Journal of Clinical Oncology. 25(18_suppl). 4096–4096. 3 indexed citations

20.

Baldi, Giacomo Giulio, et al.. (1994). Cost/benefit relationship in 46 cases of myelodysplastic syndrome (RAEB and RAEB-T): a quality assurance analysis in clinical haematology.. PubMed. 78(5). 291–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact